Insiders were net sellers of Pacira BioSciences, Inc.'s (NASDAQ:PCRX ) stock during the past year. That is, insiders sold more stock than they bought.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

Pacira BioSciences Insider Transactions Over The Last Year

The insider, Gary Pace, made the biggest insider sale in the last 12 months. That single transaction was for US$3.7m worth of shares at a price of US$30.81 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$16.45. So it may not tell us anything about how insiders feel about the current share price. Gary Pace was the only individual insider to sell over the last year.

Over the last year, we can see that insiders have bought 17.58k shares worth US$216k. But insiders sold 119.32k shares worth US$3.7m. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

I will like Pacira BioSciences better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Pacira BioSciences Insiders Bought Stock Recently

Over the last three months, we've seen a bit of insider buying at Pacira BioSciences. Insiders purchased US$33k worth of shares in that period. We like it when there are only buyers, and no sellers. But the amount invested in the last three months isn't enough for us too put much weight on it, as a single factor.

Insider Ownership Of Pacira BioSciences

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Our data indicates that Pacira BioSciences insiders own about US$8.0m worth of shares (which is 1.0% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Do The Pacira BioSciences Insider Transactions Indicate?

Insider purchases may have been minimal, in the last three months, but there was no selling at all. The net investment is not enough to encourage us much. Our analysis of Pacira BioSciences insider transactions leaves us unenthusiastic. We also note that, as far as we can see, insider ownership is fairly low, compared to other companies. Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Pacira BioSciences.

But note: Pacira BioSciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.